Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1991-01-24
1992-04-07
Gerstl, Robert
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
548136, 548141, 548142, 548143, 548144, C07D271113, A61K 3141
Patent
active
051028972
ABSTRACT:
The novel 3,5-ditertiarybutyl-4-hydroxyphenylthio-1,3,4-thiadiazoles and oxadiazoles and 3,5-ditertiarybutyl-4-hydroxyphenylmethanone-1,3,4-thiadiazoles and oxadiazoles and related compounds of the present invention are antiinflammatory agents having activity as inhibitors of 5-lipoxygenase, cyclooxygenase or both.
REFERENCES:
patent: 3971803 (1976-07-01), Rosenberger et al.
patent: 4040922 (1977-08-01), Wang et al.
patent: 4097669 (1978-06-01), Reisdorff et al.
patent: 4137237 (1979-01-01), Durant et al.
patent: 4178253 (1979-12-01), Lee et al.
patent: 4212867 (1980-07-01), Boesch
Search Report corresponding EPO Application 91-104 779.
Derwent Abstr. No. 89-151431/21.
Derwent Abstr. No. 88-199351/29.
Derwent Abstr. No. 09605y/06.
Derwent Abstr. No. 70909y/40.
Boschelli Diane H.
Connor David T.
Kostlan Catherine R.
Kramer James B.
Mullican Michael D.
Gerstl Robert
Thierstein Joan
Warner-Lambert & Company
LandOfFree
3,5-ditertiarybutyl-4-hydroxyphenyl, 1,3,4-thiadiazoles and oxad does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 3,5-ditertiarybutyl-4-hydroxyphenyl, 1,3,4-thiadiazoles and oxad, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 3,5-ditertiarybutyl-4-hydroxyphenyl, 1,3,4-thiadiazoles and oxad will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1895553